Article Details
Retrieved on: 2024-02-05 16:13:54
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article announces Dr. Steven Ryder joining MBX Biosciences' Board of Directors, leveraging his biopharmaceutical expertise to advance their biotechnological research for endocrine diseases, complementing the company's growth and development in the U.S. market.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here